Last reviewed · How we verify
NCT04762290
Dance for Children With Autism
NA trial testing Dance in Neurodevelopmental Disorders in 35 participants. Completed in 31 August 2024.
30 August 2024
Quick facts
| Lead sponsor | University of California, Los Angeles |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 35 |
| Start date | 31 January 2021 |
| Primary completion | 30 August 2024 |
| Estimated completion | 31 August 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Dance
Conditions studied
- Neurodevelopmental Disorders — all drugs for Neurodevelopmental Disorders →
Sponsor
University of California, Los Angeles
Who can join
Adults 8 to 12, any sex, with Neurodevelopmental Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Motor impairments are prominent in individuals with autism spectrum disorder (ASD) and other neurodevelopment disorders, and these impairments often impact the individual's ability to engage in organized physical activity programs (OPA). While many studies have identified dance and creative movement to be retrospectively and anecdotally therapeutic, there remains a paucity of literature regarding outcomes associated with these programs, and specifically, their impact on (1) perceived and objective gross and fine motor skills, (2) perceived ability to succeed in related or divergent goals or tasks, (3) quality of life for affected individuals and their caregivers. (4) adaptive function and socialization, (5) social communication This study explores the impact of organized dance and creative movement classes on children with autism (ages 8-12) and their caregivers. Participants will complete a set of surveys and assessments designed to measure the above metrics (labeled 1, 2, and 3) at their first study visit. This initial assessment is expected to take place within two weeks prior to beginning the intervention (either a wait period or a series of 1-hour dance classes, which children will attend weekly for 10 weeks). The second and final study visit will consist of a similar set of surveys and assessments designed to measure the same metrics within the two weeks following completion of the dance class series. Participants who have completed the wait period at this point will then begin their set of 10 weekly dance classes. Expected duration of participation in the study is no longer than 14 weeks in total.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
A novel dance intervention program for children and adolescents with developmental disabilities: a pilot randomized control trial.
Anderson JT, Toolan C, Coker E, Singer H, et al · · 2024 · cited 2× · PMID 38745176 · DOI 10.1186/s13102-024-00897-3 -
The impact of a pilot dance intervention program for children and adolescents with developmental disabilities: a randomized control trial
Anderson J, Toolan C, Coker E, Singer H, et al · · 2023 · DOI 10.21203/rs.3.rs-3256683/v1
Verify or expand the search:
- PubMed search for NCT04762290
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Dance
Trials testing the same drug.
- NCT06215027 — The Effects of Dance for Breast Cancer Patients Undergoing Surgical Treatment · NA · recruiting
- NCT04120467 — Dance as a Means to Improve Functions and Quality of Life After a Stroke · NA · terminated
- NCT04069481 — Dance for the Improvement of Balance and Gait After Stroke · NA · unknown
- NCT05113524 — Effects of Dance on the Turning Characteristics of Patients With Parkinson's Disease · NA · completed
- NCT03860649 — Effects of Different Physical Therapies and Dance in People With Parkinson's Disease · NA · unknown
Other recruiting trials for Neurodevelopmental Disorders
Currently open trials in the same condition.
- NCT07493096 — Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disor · recruiting
- NCT06915480 — Reducing Missed Appointments · Phase 3 · recruiting
- NCT06807203 — Motor-voice Assessment in Infants (MAMI) · recruiting
- NCT05815095 — Early Detection and Referral for Autism and Neurodevelopmental Disorders at the Maternal and Child Protection Services · recruiting
- NCT06974136 — tES Modalities for the Treatment of ADHD · NA · recruiting
Other University of California, Los Angeles trials
Trials by the same sponsor.
- NCT04846517 — rTMS for Aneroxia Nervosa in Youth · NA · not yet recruiting
- NCT06701760 — Sodium Lactate in Severe TBI · Phase 2 · not yet recruiting
- NCT04996667 — Effect of iNO in Patients With Submassive and Massive PE · Phase 2 · withdrawn
- NCT05067387 — Evaluation of Oral THC and CBD in Men and Women · Phase 1 · not yet recruiting
- NCT07534696 — Evaluation of Non-Invasive Pelvic Floor Neuromuscular Stimulation for Urinary Incontinence After Prostatectomy · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04762290 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of California, Los Angeles
- Last refreshed: 16 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04762290.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing